Citadel Advisors’s AdaptHealth AHCO Stock Holding History
Bought
Maintained
Sold
Other funds holding AHCO
OCA
DM
RP
SC
VPM
VCM
Citadel Advisors's AHCO Position: Q1 2026 in Review
Citadel Advisors increased its AdaptHealth (AHCO) stake by 72% in Q1 2026, buying an estimated $553K and bringing the position to 129,106 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #6656.
Citadel Advisors first reported a position in AHCO in Q1 2020 and has held it in 22 quarters since. The position peaked at $13.9M in Q1 2023. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.
- Citadel Advisors held 129,106 shares of AdaptHealth worth $1.54M as of Q1 2026.
- Citadel Advisors bought 54,056 AdaptHealth shares in Q1 2026, an estimated $553K.
- AdaptHealth made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6656 holding.
- Citadel Advisors first reported a position in AdaptHealth in Q1 2020 and has held it in 22 quarters since.
- Citadel Advisors's AdaptHealth position peaked at $13.9M in Q1 2023.
- 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.